ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.

Geoffrey R Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.